Triodos Investment Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$38.4M Buy
32,050
+6,970
+28% +$7.12M 2.34% 17
2026
Q1
$23.1M Buy
25,080
+2,600
+12% +$2.64M 1.74% 26
2025
Q4
$24.3M Buy
+22,480
New +$21.5M 1.75% 26

Other funds holding LLY

Triodos Investment Management's LLY Position: Q2 2026 in Review

Triodos Investment Management increased its Eli Lilly (LLY) stake by 28% in Q2 2026, buying an estimated $7.12M and bringing the position to 32,050 shares worth $38.4M. The position accounts for 2.34% of the portfolio, ranked #17.

Triodos Investment Management first reported a position in LLY in Q4 2025 and has held it in 3 quarters since. 4,626 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Triodos Investment Management held 32,050 shares of Eli Lilly worth $38.4M as of Q2 2026.
  • Triodos Investment Management bought 6,970 Eli Lilly shares in Q2 2026, an estimated $7.12M.
  • Eli Lilly made up 2.34% of Triodos Investment Management's portfolio in Q2 2026, its #17 holding.
  • Triodos Investment Management first reported a position in Eli Lilly in Q4 2025 and has held it in 3 quarters since.
  • 4,626 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Triodos Investment Management's 13F filing for Q2 2026, filed 29 Jul 2026.